Skip to main content
Have a personal or library account? Click to login
Mechanisms of Organophosphate Toxicity and Detoxication with Emphasis on Studies in Croatia Cover

Mechanisms of Organophosphate Toxicity and Detoxication with Emphasis on Studies in Croatia

Open Access
|Oct 2007

References

  1. Reiner E, Radić Z, Simeon-Rudolf V. Introductory overview on mechanisms of organophosphate toxicity and detoxication with emphasis on studies in Croatia. Toxicol Lett - Abstracts of The EUROTOX 2006/6 CTDC Congress 2006. 164S:S8-9.
  2. Stojiljković MP, Jokanović M. Pyridinium oximes: rationale for their selection as causal antidotes against organophosphate poisonings and current solutions for auto-injectors.200657:435-43.
  3. Dawson RM. Review of oximes available for the treatment of nerve agent poisoning.199414:17-31.
  4. Bajgar J. Organophosphates/nerve agent poisoning: mechanism of action, diagnosis, propylaxis, and treatment.200438:151-216.
  5. Gupta RC, editor. Toxicology of Organophosphate and Carbamate Pesticides. Burlington: Elsevier Academic Press; 2006.
  6. Szinicz L, Reiner E, Eyer P, guest editors, Worek F, co-editor. New Strategies in Medical Protection against Organophosphorus Compounds.2007233(special issue 1-3):1-240.
  7. Primožič I, Odžak R, Tomić S, Simeon-Rudolf V, Reiner E. Pyridinium, imidazolium, and quinuclidinium oximes: Synthesis, interaction with native and phosphorylated cholinesteerases, and antidotes against organophosphorus compounds.2004-20052:1-30. ŠDisplayed 2 June 2004Ć Available at
  8. Reiner E, Simeon-Rudolf V. Pyridinium, imidazolium and quinuclidinium compounds: toxicity and antidotal effects against the nerve agents tabun and soman.200657:171-9.
  9. Lucić Vrdoljak A, Čalić M, Radić B, Berend S, Jun D, Kuča K, Kovarik Z. Pretreatment with pyridinium oximes improves antidotal therapy against tabun poisoning.2006228:41-50.
  10. Odžak M, Čalić M, Hrenar T, Primožič I, Kovarik Z. Evaluation of monoquaternary pyridinium oximes potency to reactive tabun-inhibited human acetylcholinesterase.2007233:85-96.
  11. Odžak R, Oršulić M, Tomić S. Synthesis of glucoconjugates with heterocyclic oximes.2007233:227-8.
  12. Škare D, Radić B, Lucić A, Peraica M, Domijan A-M, Milković-Kraus S, Bradamante V, Jukić I. Adamantyl tenocyclidines: Adjuvant therapy in poisoning with organophosphorus compounds and carbamates.200276:173-7.
  13. Lucić Vrdoljak A, Radić B, Garaj-Vrhovac V, Kopjar N, Žlender V. Evaluation of antidotal effects of adamantyl derivative Tamorf in soman poisoning.200626:56-63.
  14. Radić B, Lucić Vrdoljak A, Petek MJ, Kopjar N, Želježić D. In vitro biological efficiency of tenocyclidine TCP and its adamantane derivative TAMORF.200620:1455-64.
  15. Radić Z, Reiner E, Simeon V. Binding sites on acetylcholinesterase for reversible ligands and phosphorylating agents: A theoretical mode1 tested on haloxon and phosphostigmine.198433:671-7.
  16. Reiner E. Inhibition of acetylcholinesterase by 4,4'-bipyridine and its effect upon phosphylation of the enzyme.198659:925-31.
  17. Radić Z, Reiner E, Taylor P. Role of the peripheral anionic site on acetylcholinesterase: Inhibition by substrates and coumarin derivatives.199139:98-104.
  18. Simeon-Rudolf V, Reiner E, Škrinjarić-Špoljar M, Radić B, Lucić A, Primožić I, Tomić S. Quinuclidinium-imidazolium compounds: Synthesis, mode of interaction with acetylcholinesterase and effect upon Soman intoxicated mice.199872:289-95.
  19. Simeon-Rudolf V, Kovarik Z, Radić Z, Reiner E. Reversible inhibition of acetylcholinesterase and butyrylcholinesterase by 4,4'-bipyridine and by a coumarin derivative.1999119/120:119-28.
  20. Reiner E, Simeon-Rudolf V. Cholinesterases: substrate inhibition and substrate activation.2000440(Suppl):R118-20.
  21. Reiner E, Radić Z. Mechanism of action of cholinesterase inhibitors. In: Giacobini E, editor. Cholinesterases and Cholinesterase Inhibitors. London:; 2000. p. 103-19.
  22. Simeon V, Radić Z, Reiner E. Inhibition of cholinesterases by the oximes P2AM and Toxogonin.198154:473-80.
  23. Čalić M, Lucić Vrdoljak A, Radić B, Jelić D, Jun D, Kuča K, Kovarik Z. In vitro and in vivo evaluation of pyridinium oximes: Mode of interaction with acetylcholinesterase, effect on tabun- and soman-poisoned mice and their cytotoxicity.2006219:85-96.
  24. Kovarik Z, Čalić M, Šinko G, Bosak A. Structure-activity approach in the reactivation of tabun-phosphorylated human acetylcholinesterase with bispyridinium //-aldoximes.200758:201-9.
  25. Šurina B, Nosso D, Šiftar Z, Flegar-Meštrić Z, Simeon-Rudolf V. Cholinesterase unit establishment and issuing of "Warning cards" for carriers of suxamethonium sensitive serum butyrylcholinesterase variants.200428(Suppl 2):297-304.
  26. Simeon-Rudolf V, Evans RT. Interlaboratory study into the proficiency of attribution of human serum butyrylcholinesterase phenotypes: Reference values of activities and inhibitor numbers.200151:289-96.
  27. Simeon-Rudolf V, Evans RT. Interlaboratory study into the proficiency of serum cholinesterase activity measurement.200152:299-305.
  28. Reiner E, Radić Z, Simeon V. Hydrolysis of paraoxon and phenylacetate by human serum esterases. In: Reiner E, Aldridge WN, Hoskin FCG, editors. Enzymes Hydrolysing Organophosphorus Compounds; Chichester: Ellis Horwood Ltd.; 1989. p. 30-40.
  29. Reiner E, Simeon-Rudolf V, Škrinjarić-Špoljar M. Catalytic properties and distribution profiles of paraoxonase and cholinesterase phenotypes in human sera.199582/83:447-52.
  30. Juretić D, Tadijanović M, Rekić B, Petlevski R, Simeon-Rudolf V. Paraoxonase phenotype distribution in a healthy population group from the Slavonski Brod area.200414:51-6.
  31. Geldmacher V, Mallincrodt M, Diepgen TL. The human serum paraoxonase - Polymorphism and specificity.198818:79-196.
  32. Pavković E, Simeon V, Reiner E, Sučić M, Lipovac V. Serum paraoxonase and cholinesterase activities in individuals with lipid and glucose metabolism disorders1993. 87:179-82.
  33. Reiner E, Pavković E, Simeon-Rudolf V, Sučić M, Lipovac V. Activities of serum esterases in patients with hyperlipidaemia.199669:317-25.
  34. Juretić D, Tadijanović M, Rekić B, Simeon-Rudolf V, Reiner E, Baričić M. Serum paraoxonase activities in hemodialyzed uremic patients: Cohort study.200142:146-50.
  35. Juretić D, Motejlkova A, Kunović B, Rekić B, Flegar-Meštrić Z, Vujić L, Mesić R, Lukač-Bajalo J, Simeon-Rudolf V. Paraoxonase/arylesterase in serum of patients with type II diabetes mellitus.200656:59-68.
  36. Lista otrova koji se mogu stavljati u promet [List of toxic compounds approved for the market, in Croatian]. Narodne Novine 30/2005.
  37. Vasilić Ž, Drevenkar V, Fröbe Z, Štengl B, Tkalčević B. The metabolites of organophosphorus pesticides in urine as an indicator of occupational exposure. In: Merian E, Frei RW, Lawrence JF, Brinkman UA Th, editors. Chemistry and Fate of Organophosphorus Compounds. Montreux: Gordon and Breach Science Publishers S.A.; 1987. p. 57-73.
  38. Vasilić Ž, Štengl B, Drevenkar V. Dimethylphosphorus metabolites in serum and urine of persons poisoned by malathion or thiometon.1991;119-120 479-87.
  39. Drevenkar V, Radić Z, Vasilić Ž, Reiner E. Dialkylphosphorus metabolites in the urine and activities of esterases in the serum as biochemical indices for human absorption of organophosphorus pesticides.199120:417-22.
  40. Vasilić Ž, Drevenkar V, Rumenjak V, Štengl B, Fröbe Z. Urinary excretion of diethylphosphorus metabolites in persons poisoned by quinalphos or chlorpyrifos.199222:351-7.
  41. Vasilić Ž, Drevenkar V, Štengl B, Fröbe Z, Rumenjak V. Diethylphosphorus metabolites in serum and urine of persons poisoned by phosalone.199387:305-13.
  42. Drevenkar V, Vasilić Ž, Štengl B, Fröbe Z, Rumenjak V. Chlorpyrifos metabolites in serum and urine of poisoned persons.199387:315-22.
  43. Drevenkar V, Štengl B, Fröbe Z. Microanalysis of dialkylphosphorus metabolites of organophosphorus pesticides in human blood by capillary gas chromatography and by phosphorus-selective and ion trap detection.1994290:277-86.
  44. Reiner E. Simeon-Rudolf V. Methods for measuring cholinesterase activities in human blood. In: Gupta RC, editor. Toxicology of Organophosphate and Carbamate Compounds. Burlington: Elsevier Academic Press, 2006. p. 199-208.
  45. Ellman GL, Courtney KD, Andres V, Featherstone RM. A new and rapid colorimetric determination of acetylcholinesterase activity.19617:88-95.
  46. Eyer P, Worek F, Kiderlen D, Šinko G, Štuglin A, Simeon-Rudolf V, Reiner E. Molar absorption coefficients for the reduced Ellman reagent: Reassessment.2003312:224-7.
  47. Simeon-Rudolf V, Šinko G, Štuglin A, Reiner E. Inhibition of human blood acetylcholinesterase and butyrylcholinesterase by ethopropazine.200174:173-82.
  48. Worek F, Mast U, Kiderlen D, Diepold Ch, Eyer P. Improved determination of acetylcholinesterase activity in human whole blood.1999288:73-90.
  49. Reiner E, Šinko G, Škrinjarić-Špoljar M, Simeon-Rudolf V. Comparison of protocols for measuring activities of human blood cholinesterases by the Ellman method.200051:13-8.
  50. Simeon-Rudolf V, Škrinjarić-Špoljar M, Reiner E, Orehovec Z, Jukić I, Bokan S, Smoljan B. Identification of the contents and shelf-life of indicator tubes from field kits for detection of organophosphorus compounds in the air.199748:219-24.
  51. Reiner E, Simeon V, Šimaga Š, Cizl S, Jeličić D, Šumanović V, Batinić D. A field-test for detecting organophosphorus compounds in water.199344:159-62.
  52. Reiner E, Radić Z. An enzyme test for determining isomalathion impurities in water-dispersable powders of malathion.198664:397-401.
DOI: https://doi.org/10.2478/v10004-007-0026-2 | Journal eISSN: 1848-6312 (formerly 0004-1254) | Journal ISSN: 0004-1254
Language: English, Croatian
Page range: 329 - 338
Published on: Oct 3, 2007
Published by: Institute for Medical Research and Occupational Health
In partnership with: Paradigm Publishing Services

© 2007 Elsa Reiner, Zoran Radić, Vera Simeon-Rudolf, published by Institute for Medical Research and Occupational Health
This work is licensed under the Creative Commons License.